Atypical Depression Completed Phase 3 Trials for St. John's Wort (DB01323)

IndicationStatusPhase
DBCOND0033164 (Atypical Depression)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00861978
St. John's Wort Extract LI 160 for the Treatment of Atypical DepressionTreatment